Kaskela Law LLC is investigating Evolv Technologies Holdings, Inc. (NASDAQ: EVLV) on behalf of the company’s former employees.
On July 15, 2021, NewHold Investment Corp. (“NewHold”), a publicly traded special purpose acquisition (“SPAC”) company, announced that NewHold’s stockholders had approved of an acquisition of privately held Evolv Technologies, Inc. (“Legacy Evolv”). NewHold also announced that, upon the closing of the acquisition, the combined company would be renamed Evolv Technologies Holdings, Inc. (“Evolv”) and its common stock would start trading under ticker symbol NASDAQ: EVLV.
In connection with the closing of the acquisition, many of Legacy Evolv’s executives and employees had their previously held shares/stock options of privately held Legacy Evolv converted into shares of publicly traded Evolv (NASDAQ: EVLV). The investigation seeks to determine whether this share conversion was done in a fair manner and in accordance with the securities laws, or whether former Legacy Evolv shareholders were financially harmed in connection with the conversion.
Former Legacy Evolv employees who had their shares/stock options of privately held Legacy Evolv converted into publicly traded shares of Evolv (NASDAQ: EVLV) are encouraged to contact Kaskela Law LLC (D. Seamus Kaskela, Esq. or Adrienne Bell, Esq.) at (484) 229 – 0750, or by completing the form on this page, to receive additional information about this investigation and their legal rights and options.
CONTACT:
KASKELA LAW LLC
D. Seamus Kaskela, Esq.
([email protected])
Adrienne Bell, Esq.
([email protected])
18 Campus Blvd., Suite 100
Newtown Square, PA 19073
(888) 715 – 1740
(484) 229 – 0750